Like the U.S., Europe Continues to Grapple with Cannabis Extracts
The regulatory status of cannabinoids in the EU is just as much a free-for-all as it is in the US. Various states in the US oversee hemp-derived extracts and require safety testing, but other do not. The FDA has also proven unable to develop CBD regulation, instead telling congress that cannabis extracts don’t fit into the current scope of FDA oversight.
On both sides of the Atlantic, hemp stakeholders have tried to leverage existing policy to have hemp derivatives recognized under relevant categories. In the US, seeking “GRAS” status, or (generally recognized as safe) is a designation that eventually applied to hempseed, but not to cannabis extracts.
Broadly speaking, products that have been used historically – and present no obvious signs of harm – qualify as GRAS. In Europe, the Novel Foods characterization…
01.30.2025
Diamond Green Diesel will look to Europe for RD, SAF: Valero
The most attractive markets for renewable diesel (RD) and sustainable aviation fuel (SAF) are Europe and the UK, Eric Fisher, senior vice president of US-based fuels producer Valero, said...
01.30.2025
DCO holds firm while animal fats sentiment softens amid market uncertainty
Activity in the US animal fats and oils markets eased on Thursday January 30 as the month neared its end on a more cautious note amid ongoing uncertainty.
01.30.2025
Limited hide bidding interest; some Chinese tanners engage for discounts
Several hide sellers noted limited bidding interest on Thursday January 30, except for one packer who received strong volume bids from Chinese upholstery and shoe tanners despite the ongoing...